アレルギー性鼻炎治療薬の世界市場予測2016-2026...市場調査レポートについてご紹介

【英文タイトル】Allergic Rhinitis Drugs Market Forecast 2016-2026

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 Global Allergic Rhinitis Drugs: Market Overview
1.2 Global Allergic Rhinitis Drugs Market Segmentation
1.3 Overview of Findings
1.4 Structure of the Report
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Who is This Report For?
1.9 Methodology
1.10 Frequently Asked Questions (FAQ)
1.11 Associated Visiongain Reports
1.12 About Visiongain

2. An Introduction to Allergic Rhinitis Drugs
2.1 The Pharmaceutical Industry: A Brief Introduction
2.1.1 Allergic Rhinitis Treatments – An Industry Overview
2.2 A Brief Overview of Allergy
2.3 Allergic Rhinitis
2.3.1 The Global Prevalence of Allergic Rhinitis
2.3.2 Pathophysiology of Allergic Rhinitis: IgEs and Mast Cells
2.3.3 Symptoms of Allergic Rhinitis
2.3.4 Classification of Allergic Rhinitis
2.3.4.1 Non-Allergic Rhinitis and Mixed Rhinitis
2.3.5 Seasonal Allergic Rhinitis (Hay Fever)
2.3.6 Perennial Allergic Rhinitis
2.3.7 Diagnosis of Allergic Rhinitis
2.4 Treatment of Allergic Rhinitis
2.4.1 Antihistamines
2.4.1.1 First-Generation Antihistamines
2.4.1.2 Second- And Third-Generation Antihistamines
2.4.2 Corticosteroids
2.4.2.1 First-, Second- And Third-Generation Intranasal Corticosteroids
2.4.2.2 Combination Drug Products
2.4.3 Leukotriene Receptor Antagonists
2.4.4 Cromolyn (cromoglicic acid)
2.4.5 Decongestants
2.4.6 Saline Nasal Sprays
2.4.7 Immunotherapy and Vaccines
2.5 Phases of Clinical Trials
2.6 Scope of this Report

3. The Global Allergic Rhinitis Drugs Market, 2016-2026
3.1 The Global Allergic Rhinitis Drugs Market: Market Overview
3.2 Categorisation Of The Global Allergic Rhinitis Drugs Market
3.3 The Global Allergic Rhinitis Drugs Market in 2015
3.4 The Global Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
3.5 Allergic Rhinitis Drugs: Changing Market Shares by Sector 2016-2026

4. Oral Antihistamines Market: Market Analysis And Forecast 2016-2026
4.1 Oral Antihistamines: Market Overview
4.1.1 Leading Products in the Oral Antihistamines Market, 2015
4.2 Oral Antihistamines: Market Trends and Developments, 2016
4.2.1 Patent Expiries and the Threat of Generics
4.2.2 The Increasing Switch from Prescription to Over-The-Counter Sales
4.2.3 The Potential for Combination Therapy with Intranasal Corticosteroids
4.3 Oral Antihistamines: Market Forecast 2016-2026
4.3.1 Oral Antihistamines: Changing Market Shares by Leading Drugs 2016-2026
4.4 Leading Oral Antihistamines for the Treatment of Allergic Rhinitis
4.4.1 Allegra/Allegra-D/Allegra OTC (fexofenadine) – Sanofi
4.4.1.1 Allegra/Allegra OTC: Historical Sales, 1995-2014
4.4.1.2 Allegra/Allegra OTC: Sales Forecast 2015-2026
4.4.2 Claritin/Claritin OTC (loratadine) – Bayer/ Merck & Co
4.4.2.1 Claritin/Claritin OTC: Sales Forecast 2016-2026
4.4.3 Zyrtec/Zyrtec D (cetirizine) – Johnson & Johnson/ UCB/ GSK
4.4.3.1 Zyrtec/Zyrtec D: Sales Forecast 2016-2026
4.4.5 Xyzal (levocetirizine) – Sanofi/ UCB/ GSK
4.4.5.1 Xyzal: Sales Forecast 2016-2026
4.4.6 Clarinex (desloratadine) – Merck & Co.
4.4.6.1 Clarinex: Sales Forecast 2016-2026
4.4.7 Allelock (olopatadine) – Kyowa Hakko Kirin
4.4.7.1 Allelock: Sales Forecast 2016-2026
4.4.8 Ebastel (ebastine) – AstraZeneca/Takeda/Dainippon Sumitomo
4.4.8.1 Ebastel: Sales Forecast 2016-2026
4.4.9 Talion (bepotastine) – Mitsubishi Tanabe
4.4.9.1 Talion: Sales Forecast 2016-2026
4.4.10 Other Oral Antihistamines: Sales Forecast 2016-2026

5. Intranasal Corticosteroids Market: Market Analysis and Forecast 2016-2026
5.1 Leading Products in the Intranasal Corticosteroids Market, 2015
5.2 Intranasal Corticosteroids: Market Forecast 2016-2026
5.2.1 Intranasal Corticosteroids: Changing Market Shares By Leading Drugs 2016-2026
5.3 Leading Intranasal Corticosteroids
5.3.1 Flixonase/Flonase/Flonase-OTC (fluticasone propionate) – GlaxoSmithKline
5.3.1.1 Flixonase/Flonase/Flonase-OTC Forecast, 2016-2026
5.3.2 Nasonex (mometasone) – Merck
5.3.2.1 Nasonex Forecast, 2016-2026
5.3.3 Avamys/Veramyst (fluticasone furoate) – GlaxoSmithKline
5.3.3.1 Avamys/Veramyst Forecast, 2016-2026
5.3.4 Rhinocort (budesonide) – AstraZeneca
5.3.4.1 Rhinocort Forecast, 2016-2026
5.3.5 Nasacort/Nasacort-OTC (triamcinolone) – Sanofi
5.3.5.1 Nasacort/Nasacort-OTC Forecast, 2016-2026
5.3.6 Omnaris (ciclesonide) – Dainippon Sumitomo/Takeda
5.3.6.1 Omnaris: Sales Forecast, 2016-2026
5.3.7 Beconase/Beconase AQ (beclometasone) – GlaxoSmithKline/Omega Pharma
5.3.7.1 Beconase/Beconase AQ Forecast, 2016-2026
5.3.8 Qnasl (beclometasone) – Teva
5.3.8.1 Qnas Forecast, 2016-2026
5.3.9 Zetonna (ciclesonide) – Dainippon Sumitomo
5.3.9.1 Zetonna Forecast, 2016-2026

6. Immunotherapy and Vaccines: Market Analysis and Forecast 2016-2026
6.1 Immunotherapy and Vaccines: Market Overview
6.1.1 Immunotherapy: Primed for Rapid Expansion
6.2 Leading Immunotherapy Products in the Allergic Rhinitis Market, 2015
6.3 Allergic Rhinitis Immunotherapy: Market Trends and Developments, 2016
6.3.1 Subcutaneous and Sublingual Immunotherapy
6.3.2 Expansion into the US Market
6.3.3 Standardisation of Immunotherapy Products
6.3.4 Immunotherapy as a Preventative Treatment
6.4 Allergic Rhinitis Immunotherapy: Market Forecast 2016-2026
6.4.1 Allergic Rhinitis Immunotherapy: Changing Market Shares by Leading Products 2016-2026
6.5 Immunotherapy Type – By Route of Administration, 2015
6.6 Leading Immunotherapy Products for Allergic Rhinitis
6.6.1 Staloral (Grass pollen allergen extract) – Stallergenes
6.6.1.1 Staloral: Sales Forecast 2016-2026
6.6.2 Alutard SQ (Grass pollen allergen extract) – ALK-Abelló
6.6.2.1 Alutard SQ: Sales Forecast 2016-2026
6.6.3 Grazax/Grastek (Timothy grass pollen allergen extract) – ALK-Abelló/Merck
6.6.3.1 Grazax/Grastek: Sales Forecast 2016-2026
6.6.4 Oralair (Grass pollen allergen extract) – Stallergenes/Greer
6.6.4.1 Oralair: Sales Forecast 2016-2026
6.6.5 Ragwitek (Short ragweed pollen allergen extract) – Merck
6.6.5.1 Ragwitek: Sales Forecast 2016-2026
6.6.6 Other Allergic Rhinitis Immunotherapy Products: Sales Forecast 2016-2026

7. The Intranasal Antihistamines Market: Market Analysis and Forecast 2016-2026
7.1 Leading Products in the Intranasal Antihistamines Market, 2015
7.2 Intranasal Antihistamines: Market Trends and Developments, 2016
7.3 Intranasal Antihistamines: Market Forecast 2016-2026
7.4 Leading Intranasal Antihistamines
7.4.1 Dymista (azelastine/fluticasone) – Meda Pharmaceuticals
7.4.1.1 Mylan Acquires Meda Pharmaceuticals
7.4.1.2 Dymista: Sales Forecast 2016-2026
7.4.2 Generic Intranasal Azelastine
7.4.2.1 Generic Intranasal Azelastine: Sales Forecast, 2016-2026
7.4.3 Astepro (azelastine) – Meda Pharmaceuticals
7.4.3.1 Astepro: Sales Forecast 2016-2026
7.4.4 Patanase (olopatadine) – Novartis
7.4.4.1 Patanase: Sales Forecast 2016-2026
7.4.5 Astelin (azelastine) – Meda Pharmaceuticals
7.4.5.1 Astelin: Sales Forecast 2016-2026

8. Leading National Markets for Allergic Rhinitis Drugs, 2016-2026
8.1 The Allergic Rhinitis Drugs Market by Region
8.1.1 The Global Distribution of Allergic Rhinitis Drugs in 2015
8.2 Leading National Markets: Forecast 2016-2026
8.2.1 Changing Market Shares by Region, 2016-2026
8.3 Regional Allergic Rhinitis Drugs Markets: Analysis and Forecasts, 2016-2026
8.3.1 United States: The Largest Allergic Rhinitis Drugs Market
8.3.1.1 US Allergic Rhinitis Drugs Market: Trends and Developments
8.3.1.1.1 The Trend of Rx-to-OTC Switching
8.3.1.2 US Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2 EU5
8.3.2.1 EU5 Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2.2 EU5 Markets: Changing Market Shares by Country, 2016-2026
8.3.2.3 Germany
8.3.2.3.1 Germany: Reform of AMNOG Pharmaceutical Rebate Law
8.3.2.3.2 German Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2.4 UK
8.3.2.4.1 UK: Increasing Burden of Allergy
8.3.2.4.2 UK Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2.5 France
8.3.2.5.1 France: Social Security Finance Act 2015
8.3.2.5.2 French Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2.6 Italy
8.3.2.6.1 Italy: Government Cost Cutting Measures Impacting Market Growth
8.3.2.6.2 Italian Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2.7 Spain
8.3.2.7.1 Spanish Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.6 China
8.6.1 Air Pollution Associated With Increasing Prevalence
8.6.2 Expansion of Healthcare Coverage and Reimbursement in China
8.6.3 Chinese Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.7 Japan
8.7.1 Cedar Reforestation and the Hay Fever Epidemic
8.7.2 Genetically Modified Rice as Immunotherapy
8.7.3 Effects of the Rising Levels of Generic Drug Penetration
8.7.4 Japanese Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.8 Russia
8.8.1 How Will Russia’s Economic Status Affect Its Pharma Industry?
8.8.2 Russian Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.9 India
8.9.1 The Impact of the Drug Prices Control Order on Indian Pharma
8.9.2 India’s Expansion of Healthcare Provision
8.9.3 Indian Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.10 Brazil
8.10.1 How Will Brazil’s Growing Healthcare Influence Allergic Rhinitis Drugs
8.10.2 Brazilian Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.12 Rest of the World
8.12.1 Rest of the World Allergic Rhinitis Drugs Market: Market Forecast 2016-2026

9. Leading Companies in the Allergic Rhinitis Drugs Market, 2016-2026
9.1 Allergic Rhinitis Drugs – An Evolving Market Space
9.1.1 Leading Companies in the Allergic Rhinitis Drugs Market, 2016
9.2 ALK-Abelló
9.2.1 ALK-Abelló: Allergic Rhinitis Drugs Portfolio, 2016
9.2.2 ALK-Abelló: Recent Developments
9.2.2.1 Acarizax Launched in Europe progressing to International Roll-Out
9.2.2.2 ALK Collaborates With EddingPharm to Boost China Sales
9.2.2.3 ALK-Abelló: Sales Forecast 2016-2026
9.2.2.4 ALK-Abelló: Allergic Rhinitis Drug Development Pipeline, 2016
9.3 GlaxoSmithKline (GSK)
9.3.1 GlaxoSmithKline: Allergic Rhinitis Drugs Portfolio, 2016
9.3.2 GlaxoSmithKline: Sales Forecast 2016-2026
9.4 Johnson & Johnson
9.4.1 Johnson & Johnson: Allergic Rhinitis Drugs Portfolio, 2016
9.4.2 Johnson & Johnson: Recent Developments
9.4.2.1 Manufacturing Recalls At McNeil Consumer Healthcare
9.4.2.2 Johnson & Johnson: Sales Forecast 2016-2026
9.5 Kyowa Hakko Kirin
9.5.1 Kyowa Hakko Kirin: Allergic Rhinitis Drugs Portfolio, 2015
9.5.2 Kyowa Hakko Kirin: Sales Forecast 2016-2026
9.6 Merck & Co.
9.6.1 Merck: Allergic Rhinitis Drugs Portfolio, 2016
9.6.2 Merck: Recent Developments
9.6.2.1 Bayer Acquires Merck’s Consumer Health Business
9.6.2.2 FDA Rejects Singulair OTC Switch
9.2.6.3 Merck: Sales Forecast 2016-2026
9.2.6.4 Merck: Allergic Rhinitis Drug Development Pipeline, 2016
9.7 Sanofi
9.7.1 Sanofi: Allergic Rhinitis Drugs Portfolio, 2016
9.7.2 Sanofi: Sales Forecast 2016-2026
9.8 Stallergenes Greer
9.8.1 Stallergenes: Allergic Rhinitis Drugs portfolio, 2015
9.8.2 Stallergenes Greer: Sales Forecast 2016-2026
9.8.3 Stallergenes Greer: Allergic Rhinitis Drug Development Pipeline, 2015
9.9 UCB
9.9.1 UCB: Allergic Rhinitis Drugs Portfolio, 2015
9.9.2 UCB: Sales Forecast 2016-2026
9.10 Other Leading Companies within the Allergic Rhinitis Drugs Market

10. Allergic Rhinitis Drugs: Research and Development Pipeline, 2016-2026
10.1 Trends and Developments in the Allergic Rhinitis Pipeline
10.2 The R&D Pipeline for Oral Antihistamines, 2016
10.2.1 Talion (bepotastine) – Mitsubishi Tanabe
10.2.2 ZPL-3893787 (histamine H4R antagonist) – Ziarco Pharma
10.3 The R&D Pipeline for Intranasal Corticosteroids, 2016
10.3.1 APC-3000 (HFA inhaled corticosteroid) – Adamis Pharmaceuticals
10.3.2 TBS-6 – Trimel Pharmaceuticals
10.4 The R&D Pipeline for Immunotherapy in Allergic Rhinitis, 2016
10.4.1 Actair (house dust mite SLIT; STG320) – Stallergenes/Shionogi & Co
10.4.2 AllerT (subcutaneous birch pollen immunotherapy) – Anergis
10.4.3 Depigoid Birch 5000 (birch pollen allergen extract, Leti Pharma
10.4.4 House Dust Mite SLIT-Tablet (MK-8237) – ALK-Abelló/Merck/Torii
10.4.5 Pollinex Quattro (subcutaneous immunotherapies) – Allergy Therapeutics
10.4.6 gp-ASIT+ (grass pollen allergen fragments) – Biotech Tools
10.4.7 Betula verrucosa (Bet v) 1 allergen – Stallergenes Greer
10.5 The R&D Pipeline for Other Allergic Rhinitis Drugs
10.5.1 S-555739 (prostaglandin D2 receptor antagonist) – Shionogi
10.5.2 DSP-3025/AZD-8848 (toll-like receptor 7 agonist) – Dainippon Sumitomo/ AstraZeneca
10.5.3 GSK2245035 (toll-like receptor 7 agonist) – GSK
10.5.4 HP-3060 (transdermal long-acting tape) – Hisamitsu
10.5.5 MRX-4 (anti-inflammatory agent) – Celsus Therapeutics

11. Qualitative Analysis of the Allergic Rhinitis Drugs Market, 2016-2026
11.1 Market Factors Influencing Allergic Rhinitis Drugs
11.2 SWOT Analysis Of The Global Allergic Rhinitis Drugs Market, 2016-2026
11.2.1 Strengths
11.2.1.1 OTC-Switch Facilitating Ease Of Consumer Access
11.2.1.2 The Established Role Of Allergic Rhinitis Drugs In Treatment
11.2.1.3 Allergic Rhinitis And The Rising Unmet Clinical Need
11.2.1.4 Rising Profile of Allergic Rhinitis In Various Regions Driving Healthcare Provision
11.2.2 Weaknesses
11.2.2.1 Intranasal Corticosteroids And Patients’ Satisfaction Rates
11.2.2.2 Increasing Penetration Of Generic Drug Products
11.2.2.3 The Challenge Raised By The Low Volume Of Pipeline Developments
11.2.3 Opportunities
11.2.3.1 Growth In Emerging Markets Outstripping Established Markets
11.2.3.2 Rx-to-OTC Switching And The Effects On Revenue Potential
11.2.3.3 Combination Drug Products Providing Rising Efficacy Profiles
11.2.3.4 The Emergence Of Immunotherapy In Allergic Rhinitis
11.2.4 Threats
11.2.4.1 Cost-Containment As A Growth Restraint
11.2.4.2 Rising Cost Of APIs And Manufacturing
11.2.4.3 Patent Expiries And The Resultant Loss Of Revenue
11.3 Porter’s Five Force Analysis of the Global Allergic Rhinitis Drugs Market, 2016-2026
11.3.1 Power of Buyers
11.3.2 Power Of Suppliers
11.3.3 Threat of Substitutes
11.3.4 Threat Of New Entrants
11.3.5 Rivalry Among Competitors

12. Conclusions
12.1 Overview of Current Market Conditions and Market Forecast, 2015-2026
12.2 Leading Sectors in the Allergic Rhinitis Drugs Market in 2015
12.3 Leading Regions in the Allergic Rhinitis Drugs Market in 2015
12.4 Leading Companies in the Allergic Rhinitis Drugs Market, 2015
12.5 What Does The Future Hold For Allergic Rhinitis Drugs?


【レポート販売概要】

■ タイトル:アレルギー性鼻炎治療薬の世界市場予測2016-2026
■ 英文:Allergic Rhinitis Drugs Market Forecast 2016-2026
■ 発行日:2016年9月
■ 調査会社:visiongain
■ 商品コード:VGAIN61118
■ 調査対象地域:グローバル
  • ソフトウェア定義ペリメーター(SDP)の世界市場2019-2023
    About this market The rising number of network attacks globally, has led to the software-defined perimeter market’s growth during the next few years. The network attacks being increased rapidly had led to the need for SDP has increased in recent years. The recent cyber- attacks including the DDoS, man-in-the-middle, and APTs faced by many corporates and enterprises had in turn, gained attention fo …
  • データセンターセキュリティの世界市場2017-2021
    ABSTRACTAbout Data Center Security Data center security solutions safeguard confidential data against unauthorized external access and malicious software. The increased adoption of cloud-based services and virtualization has fostered the need for advanced security mechanisms that must be implemented in data centers worldwide. Enterprises can deploy on-demand services quickly and efficiently using …
  • 風力発電タービンブレードの世界市場
    The report provides detailed analysis of the wind turbine rotor blade market, which is growing in sync with the growing demand for turbines used to produce wind energy. The market has been geographically segmented into the regions of Asia-Pacific, North America, Europe, the Middle East and Africa, and South America. The market was segmented further as per the type of materials used in the manufact …
  • 世界の帯域幅市場予測サービス(年間購読)
    TeleGeography’s Global Bandwidth Forecast Service provides detailed forecasts of bandwidth demand, supply, prices and revenues. Every quarter, subscribers receive a concise written summary of the market outlook and a comprehensive forecast spreadsheet.
  • 透過キャッシングサービスの世界市場2015-2019
    About Transparent Caching Caching is the temporary storage of web content for faster subsequent access. Transparent caching is a solution that enables the service provider to offload a significant amount of content in a cached copy of the popular content close to the edge of the network, which is delivered to an end-user directly from the edge of the network rather than from the source. It is invi …
  • 軍用センサーの世界市場予測(~2025年)
    Increasing demand for unmanned vehicles and ongoing military modernization programs are expected to fuel the growth of the military sensors market across the globe. The military sensors market is projected to grow from USD 24.7 billion in 2019 to USD 33.2 billion by 2025, at a CAGR of 5.1% from 2019 to 2025. Some of the factors that are expected to fuel the growth of the military sensors market ar …
  • Constellation Energy Partners LLC:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013
    Constellation Energy Partners LLC Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Constellation Energy Partners LLC Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The repor …
  • 世界の発電産業における二酸化炭素貯留(CCS)市場2016-2020
    About the Carbon Capture and Storage (CCS) in Power Generation Market Carbon capture and storage or storage (CCS) is one of the novel ideas that promises to aid this aspect by reducing the amount of carbon dioxide, which is released into the atmosphere during the operation of fossil fuel dependent industries such as power generation and oil and gas processing. The basic functioning of the CCS tech …
  • クラウドコンピューティング、ネットワークインフラ、ソフトフェアサービス、及びプラットフォームサービスにおける仮想化(Virtualization in Cloud Computing, Network Infrastructure, Software Services and Platform Services)
    Virtualization within a computing context refers the act of creating a virtual version of a resource including, but not limited to a virtual computer hardware platform, operating system (OS), storage device, or computer network resources. Hardware virtualization or platform virtualization refers to the creation of a virtual machine that acts like a real computer with an operating system. Virtualiz …
  • ペットフード包装の世界市場:包装材料、パッケージ種類、食品種類、ペット種類、地域別分析
    As consumers are becoming more concerned towards health of their pets, they are looking for quality packaging that can protect pet food products. Factors such as the improving global economy, increase in pet ownership, high disposable income, changing lifestyles, pet humanization, and the growing middle-class families in emerging countries such as China and India have increased the consumption of …
  • グローバルにおけるCRM(顧客関係管理)市場(2014-2018)
    About CRM Customer relationship management is a combination of organisational strategy, information systems and technology that is focused on providing better customer service. CRM is defined as a management philosophy that aims to create, develop and enhance customer relationships, so as to maximise customer value, corporate profitability and thus shareholders’ value. A category of enterprise sof …
  • グローバル・デジタルカメラ市場動向(2014-2018)
    About Digital Cameras A digital camera is an optical device which is used to capture images and videos. These images and videos are saved in digital format, unlike traditional cameras, where the images are stored on photographic film. Digital cameras can be classified into built-in lens cameras, such as point-and-shoot cameras, and interchangeable lens cameras, such as DSLRs and MILCs. A DSLR came …
  • ドイツの病院用品市場(~2021)
    Germany Hospital Supplies Market Outlook to 2021 - Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Operating Room Equipment, Patient Examination Devices, Sterilization Equipment and Syringes and Needles Summary GlobalData’s new report, "Germany Hospital Supplies Market Outlook to 2021 - Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Operating Ro …
  • グリッドスケール蓄電池市場予測(2014-2024)
    The grid scale battery storage market is largely an emerging one, especially when compared to other energy storage systems. Most grid scale batteries are either too expensive or not yet fully tested and understood in a real-life environment - or both. However, pressed by high and rising renewable energy capacity brought online, an increasing number of governments around the world are considering a …
  • Gouty Arthritis (Gout):グローバル臨床試験レビューH2, 2013
    Gouty Arthritis (Gout) Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Gouty Arthritis (Gout) Global Clinical Trials Review, H2, 2013" provides data on the Gouty Arthritis (Gout) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gouty Arthritis (Gout). It includes an overview of the trial numbers and …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。